Kaleido Biosciences, Inc. (KLDO)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Aug 14, 2025, 8:00 PM EDT
Kaleido Biosciences Market Cap
Kaleido Biosciences has a market cap or net worth of $43.00 as of August 15, 2025. Its market cap has decreased by -99.50% in one year.
Market Cap
43.00
Enterprise Value
n/a
Revenue
1.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since February 28, 2019, Kaleido Biosciences's market cap has decreased from 413.61M to 43.00, a decrease of -100.00%. That is a compound annual growth rate of -91.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 43.00 | - |
| Dec 31, 2024 | 43.00 | - |
| Dec 29, 2023 | 43.00 | -99.80% |
| Dec 30, 2022 | 21.31K | -99.98% |
| Dec 31, 2021 | 101.80M | -68.91% |
| Dec 31, 2020 | 327.44M | 117.13% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 781.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 580.89M |
| Glass House Brands | 567.91M |
| American Oncology Network | 379.23M |
| Northwest Biotherapeutics | 363.17M |
| CytoDyn | 344.75M |